Study links dihydropyridine calcium channel blockers to worse kidney outcomes in type 2 diabetes patients

A study presented at the European Renal Association Congress found that dihydropyridine calcium channel blockers (DCCBs), a commonly prescribed antihypertensive medication, may be linked to worse kidney outcomes in patients with type 2 diabetes and diabetic kidney disease. Resear